Home > News > Headline News > Archive

Click on title to read the full article.

Preliminary study suggests procedure may buy time for those with advanced disease

March 28, 2012

In a small and preliminary study, researchers report that they successfully froze secondary tumors in patients with incurable breast cancer.

Generic version of Herceptin? Synthon Successfully Concluded Phase I Clinical Trial for Trastuzumab

March 23, 2012

By Therapeutics Daily

Synthon today announced that it has successfully concluded a phase I clinical trial for trastuzumab, a biosimilar to Herceptin © , for treatment of breast cancer and gastric cancer. The company will now initiate a phase III clinical trial for trastuzumab, bringing an affordable alternative for treatment of breast and gastric cancer closer to the market.

Cancer cells in blood predict chances of survival and can help target breast cancer treatment

March 22, 2012

By ECCO-the European CanCer Organisation

When we find CTCs with a different HER2 status from that of the primary tumour or the metastasis, we will evaluate the advantage of changing the therapy regimen.

AACR Honors Yibin Kang, Ph.D., With Award for Outstanding Achievement in Cancer Research

March 21, 2012

By American Association for Cancer Research (AACR)

Kang is being recognized for his research in furthering the molecular understanding of cancer metastasis.

Combination Therapy with Pertuzumab Offers New Option in Metastatic Breast Cancer

March 16, 2012

By The Oncology Pharmacist

Pertuzumab, which binds to subdomain II of the growth domain, offers a complementary mechanism of action that, in combination with that of trastuzumab, enhances the blockade of HER2 signaling and potentially produces greater antitumor activity, as has been demonstrated in phase 2 studies.

First U.S. patient treated with the STAR™ ablation system at James Graham Brown Cancer Center

March 16, 2012

The James Graham Brown Cancer Center and DFINE Inc. today (March 14) announced that the first U.S. patient was successfully treated using the Spinal Tumor Ablation with Radiofrequency (STARTM) System.

Next-generation Sequencing in Metastatic Triple-negative Breast Cancer Yields Rewards

March 15, 2012

By Caroline Helwick

The startling molecular heterogeneity of metastatic triple-negative breast cancer is now obvious and helps to explain the poor outcomes observed in this patient subset.

Inhibiting cell migration in breast cancer

March 14, 2012

By Friedrich Miescher Institute for Biomedical Research

The scientists in the groups of Brian A. Hemmings and Prof. Curzio Rüegg have been able to elucidate the signaling events that promote invasive behavior and metastasis in breast cancer.

Viruses help stop growth of breast cancer cells

March 9, 2012

By Ronan McGreevy

GENES INJECTED through a virus into breast cancer tumour cells have stopped the cells growing, Cork-based researchers have found. The form of gene therapy is in its infancy but is part of a worldwide drive to target cancer cells using benign viruses.

Cathepsin B Inhibition Limits Bone Metastasis in Breast Cancer

March 8, 2012

By Belinda S. Parker

Metastasis to bone is a major cause of morbidity in breast cancer patients, emphasizing the importance of identifying molecular drivers of bone metastasis for new therapeutic targets.

 1 2 >